Oral Diseases and Disorders Research

Active

Assistance listing
93.121
Agency
Grant awards
10,479 $11,573,534,602 in federal obligations

Program facts

Also known as
Dental, Oral and Craniofacial Research.
Assistance types
  • Project Grant
  • Cooperative Agreement
  • Block Grant
Treasury account
  • 75-0873-0-1-550
More information

Program details come from SAM.gov Assistance Listings. Updated . Grant award figures come from USAspending.gov.

About this program

The Department of Health and Human Services National Institutes of Health, specifically the National Institute of Dental and Craniofacial Research (NIDCR), funds basic, translational, and clinical research in dental, oral, and craniofacial health and disease through Assistance Listing 93.121, with the most recent grant award dated March 1, 2030.

The program funds research spanning molecular mechanisms of tooth and craniofacial development; genetic and environmental drivers of oral diseases including periodontitis, caries, and oral cancer; salivary gland dysfunction and regeneration; temporomandibular joint disorders; craniofacial birth defects and regeneration; orofacial pain pathways; and oral health-systemic disease relationships. Recent awards exemplify this scope: mechanistic studies of mandibular fracture healing through the NG2/CSPG4 signaling pathway; investigation of myeloid cell evolution during oral cancer initiation; characterization of ciliopathy-driven pharyngeal arch deficiencies; and gene therapy targeting trigeminal nociceptors for chronic pain. The program also funds translational work on novel oral cancer immunotherapies, nanomedicine platforms for periodontal disease, red-light therapy for restorative dentistry, and salivary gland regeneration approaches.

The portfolio is heavily dominated by Project Grants (85% of 10,479 total awards), with smaller shares of Cooperative Agreements (11%) and Block Grants (4%). Funding concentrates within NIH: NIDCR itself accounts for 3,253 awards and $6.94 billion in federal dollars obligated, while the broader NIH funding base contributed 6,874 awards and $2.81 billion. The combined federal dollars obligated across all funders total $11.57 billion, with non-federal cost-sharing contributing an additional $510 million. Typical recent grant magnitudes range from $43 thousand to $694 thousand for Project Grants, with some Cooperative Agreements and larger mechanisms reaching $995 thousand.

Recent grant opportunities remain limited. No active grant opportunities are presently open with imminent deadlines under 93.121. However, multiple parent NOFOs and collaborative mechanisms remain available through the broader NIH portfolio—including the Parent R35 Investigator-Focused Award (posted July 2026), the Academic Career Excellence K32 Award (due July 2029), Small Business Transition Grants, and the Collaborative Program Grant for Interdisciplinary Teams—that welcome applications in dental, oral, and craniofacial research areas aligned with NIDCR's mission. The program shows sustained annual award volume at 220–258 grants per year in recent years (2025–2026), indicating steady demand and continued funding availability for qualified applicants in the oral and craniofacial research space.

Objective and description

Objective

NIDCR extramural research provides research funds to support basic, translational, and clinical research in dental, oral, and craniofacial health and disease through grants, cooperative agreements, including small business research through the Small

Description

The mission of the National Institute of Dental and Craniofacial Research (NIDCR) is to advance fundamental knowledge about dental, oral, and craniofacial (DOC) health and disease and translate these findings into prevention, early detection, and treatment strategies that improve overall health for all individuals and communities across the lifespan.

Eligibility

Applicant eligibility

Research Project Grants: Scientists at universities, colleges, medical and dental schools, hospitals, laboratories, and other public or private nonprofit and for-profit institutions. NRSA, career development awards and career transition awards: (1) Nonprofit domestic organizations may apply for institutional awards. (2) Individual candidates or applicants must arrange sponsorship by a public or nonprofit private institution having staff and facilities appropriate to the proposed research training program. (3) All NRSA, career development awardees, and NIDCR postdoctoral to faculty position awards must be citizens, or non-citizen nationals of the United States or have been admitted to the United States for permanent residence. (4) Extramural career transition postdoctoral to tenure track faculty or equivalent position and the R90 component of T90/R90 grants support non-citizen dentists. (4) To be eligible, postdoctoral NRSA, intramural to extramural career transition awardees, and career development awardees must have a professional or scientific degree (M.D., Ph.D., D.D.S., D.V.M., Sc.D., D.Eng., or equivalent domestic or foreign degree). Institutional applicants must be able to provide the staff and facilities suitable for the proposed research education or research training. SBIR and STTR grants: Can be awarded only to domestic small business concerns that meet the following criteria: 1) Is organized for profit, with a place of business located in the United States, which operates primarily within the United States or which makes a significant contribution to the United States economy through payment of taxes or use of American products, materials or labor; 2) Is in the legal form of an individual proprietorship, partnership, limited liability company, corporation, joint venture, association, trust or cooperative, except where the form is a joint venture, there must be less than 50 percent participation by foreign business entities in the joint venture; 3) Be a concern which is more than 50% directly owned and controlled by one or more individuals (who are citizens or permanent resident aliens of the United States), other business concerns (each of which is more than 50% directly owned and controlled by individuals who are citizens or permanent resident aliens of the United States), or any combination of these; no single venture capital operating company, hedge fund, or private equity firm may own more than 50% of the concern, 4) Has, including its affiliates, not more than 500 employees, and 5) meets the other regulatory requirements found in 13 C.F.R. Part 121. For STTR awards, the small business must "partner" with a research institution in a cooperative research and development project. In both Phase I and Phase II for both SBIR and STTR, the research must be performed in the U.S. and its possessions. To be eligible for funding, all grant applications must be evaluated for scientific merit and program relevance by a scientific peer review group and the National Advisory Dental and Craniofacial Research Council

Beneficiary eligibility

Health professionals, graduate students, undergraduate students, health professional students, scientists, researchers, and any nonprofit or for-profit organization, company or institution engaged in biomedical research.

Uses of assistance

Research Project Grants and Cooperative Agreements: provide funds for salaries, equipment, supplies, travel, and other expenses associated with scientific investigation in the dental, oral and craniofacial health sciences. They are awarded to universities, colleges, medical and dental schools, hospitals, and other nonprofit and for-profit institutions. Awards include investigator-initiated project grants, exploratory and developmental grants, small grants, center grants, conference grants, and career development awards. Individual and institutional dual degree (DDS or DMD and PhD) awards provide support for research training and career development in basic, clinical and translational science. National Research Service Awards (NRSAs) provide support for research training in specified biomedical areas, and can be made to institutions to enable them to accept individuals for research training. Postdoctoral scientists who receive NRSAs may be obligated upon termination of the award to comply with service and payback provisions. SBIR Phase I grants (duration of approximately 6 months) provide support to establish the technical merit and feasibility of a proposed research effort that may lead to a commercial product or process. Phase II grants support the continuation of the research initiated in Phase I to further develop the commercial products or process initiated in Phase I. Only Phase I awardees are eligible to receive Phase II support. STTR Phase I grants (duration of typically 1 year) support cooperative efforts between small businesses and research institutes to determine the scientific and technical merit, and commercial feasibility of a product or process with potential for commercial application. Phase II funding is based on the results of the research initiated in Phase I and the scientific and technical merit, and commercial potential of the Phase II application.

Use restrictions

As per requirements and restrictions described in NOFO.

Length and time phasing of assistance

Research Project Grants: Approval of a project includes a determination of support for the authorized project period (generally not to exceed 5 years). Awards to support the project are made on an annual basis. At the time of initial award, the grant provides funds for the conduct of the project during the first budget period (usually 12 months) and the Notice of Grant Award indicates the support recommended and expected to be made available for the remainder of the project beyond the approved project period, an application for renewal must be submitted in accordance with the deadline dates and instructions attached to the form. SBIR Phase I awards are generally for 6 months; Phase II awards normally are for 2 years. STTR Phase I awards are generally for 1 year; Phase II awards are for 2 years.

How to apply

Preapplication coordination

Preapplication coordination is not applicable. Environmental impact information is not required for this program. This program is excluded from coverage under E.O. 12372.

Criteria for selecting proposals

The primary criteria for evaluating grant applications include assessment of: (1) the scientific merit, significance and overall impact of the proposed study and its objectives; (2) the competency of the proposed investigator(s) to successfully pursue the project; (3) the innovation and novelty of the concepts, approaches, or methodologies; (4) the technical adequacy of the experimental design and approach; (5) the adequacy of the available proposed facilities and resources; (6) the necessity of the budget components requested in relation to the proposed project; and (7) the relevance and importance to the posted institute program objectives. Also evaluated, where applicable, but not scored are: (1) protections for human subjects; (2) inclusion of women, minorities, and children; (3) vertebrate animal welfare; and (4) adequate protection of research personnel and/or the environment, biosafety, biocontainment and the security of select agents; (5) resource sharing plans; (6) authentication of key biological and/or chemical resources, (7) budget and period of support. In addition, the following criteria will be used in considering the scientific and technical merit of SBIR/STTR Phase I grant applications: the potential of the proposed research for commercial application. Phase II grant applications will reviewed based upon the following criteria: (1) The degree to which the Phase I objectives were met and feasibility demonstrated; (2) the scientific and technical merit of the proposed approach for achieving the Phase II objectives; (3) the technological innovation, originality, or societal importance of the proposed research; and (4) the potential of the proposed research for commercial application. NRSA individual fellowship applications will be evaluated for: (1) overall impact/merit; (2) suitability of the applicant; (3) qualifications of the sponsor(s)/collaborator(s); (4) scientific merit of the research training plan; (5) training potential; and (6) institutional environment and commitment to training. NRSA institutional training grants are assessed for: (1) overall impact; (2) merit of the training program and institutional environment; (3) the experience and success of the training program directors, PIs, and mentors; (4) the trainee recruitment plan and selection; and (5) the training record of the program and/or institution. Career Development and Career Transition applications will be evaluated for: (1) overall impact; (2) qualifications of the candidate; (3) the career plan and career goals/objectives of the candidate; (4) scientific merit of the research plan. (5) qualifications of the mentor(s), consultant(s) and collaborator(s); and (5) institutional environment and commitment to career development.

Award procedure

All accepted grant applications competing for research project grants, career development awards, and NSRA awards are reviewed by two advisory groups. Primary review is conducted by an initial review group composed of extramural peer scientists, and secondary review by the National Advisory Dental and Craniofacial Research Council (NADCRC). Secondary review of NRSA fellowship applications is conducted by NIDCR staff rather than by the NADCRC. All accepted SBIR/STTR applications are evaluated for scientific and technical merit by an appropriate initial review group and by the NADCRC. All applications receiving a priority score compete for available SBIR/STTR set-aside funds on the basis of scientific and technical merit and commercial potential of the proposed research, program relevance, and program balance among the areas of research.

Time to approval or disapproval

Research Project Grants, SBIR/STTR, and NSRA: From 6 to 9 months.

Renewals

Grants: Applications for approval beyond the approved project period must be submitted at least 6 to 9 months in advance of the termination date. NRSA: Institutional Awards may be made up to 5 years. No individual may receive NIH/NRSA support at the postdoctoral level for more than 3 years, and total support of more than 6 years, unless a specific waiver is requested and approved.

Appeals

A Principal Investigator (PI) may question the technical or procedural aspects of the review of his/her application by communicating with the program staff of the Institute. A description of the NIH Peer Review Appeal procedures is available on the NIH home page: http://grants.nih.gov/grants/peer_review_process.htm#Appeals and in the Notice: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-11-064.html.

Grant opportunities

Opportunity Status Posted Applications due
Investigator-Focused Award (Parent R35) PAR-28-037 Forecasted —
Academic Career Excellence (ACE) Award (K32 Independent Clinical Trial Not Allowed) PAR-27-062 Open
Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional) PAR-27-040 Forecasted —
Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional) PAR-27-039 Forecasted —
NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed) RFA-EB-26-004 Past —
Collaborative Program Grant for Interdisciplinary Teams (RM1 Clinical Trial Optional) PAR-27-003 Open
NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) RFA-LM-28-001 Open
HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required) PAR-27-045 Open
Institutional Mentored Career Development Award (Parent K12) (Clinical Trials Not Allowed) PA-27-030 Open
Lasker Clinical Research Scholar's Program (Si2/R00 Clinical Trial Optional) PAR-27-076 Open
NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional) PA-26-002 Open
NIH Research Education Program - Research Experiences (Parent R25 - Clinical Trial Not Allowed) PA-27-036 Open
NIH Research Educational Program - Mentoring Activities & Networks (Parent R25/UE5 - Clinical Trial Not Allowed) PA-27-035 Open
Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional) RFA-AI-27-018 Open
Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed) PAR-28-090 Open
INCLUDE Project: Exploratory/Developmental Research Awards for Down syndrome (R21 Clinical Trial Not Allowed) RFA-OD-27-003 Open
INCLUDE Project: Transformative Research Awards for Down syndrome (R01 Clinical Trial Not Allowed) RFA-OD-27-004 Open
NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01 Clinical Trial Not Allowed) PAR-27-051 Open
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required) PAR-28-022 Open
Dental Primary Care Practice-Based Research Network: Clinical Trial or Observational Study Planning and Implementation Cooperative Agreement PAR-26-052 Past —
Dental Primary Care Practice-Based Research Network: Coordinating Center RFA-DE-27-004 Past —
Dental Primary Care Practice-Based Research Network: Administrative and Resource Center RFA-DE-27-003 Past —
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) PA-26-001 Open
Limited Competition: Instrumentation Grant Program for Resource-Limited Institutions (S10 - Clinical Trial Not Allowed) PAR-27-067 Open
Causal Hypotheses on the Oral-Systemic Health Impacts of Human Behaviors among People with Chronic Conditions (U01 Clinical Trial Not Allowed) PAR-27-057 Open
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science 25-542 Closed
NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed) PAR-27-058 Open
Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional) PAR-27-096 Open
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) PA-27-100 Open
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) PA-27-102 Open
NIH Research Education Program - Courses, Curriculum & Methods (Parent R25 - Clinical Trial Not Allowed) PA-27-034 Open
Predoctoral to Postdoctoral Transition Award (Parent F99/K00 - Clinical Trial Not Allowed) PA-27-037 Open
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional) PAR-27-098 Open
Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed) PAR-25-442 Open
NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed) PAR-27-077 Open
Small Business Translator: MedTech and Digital Health Technologies FOR-NS-25-017 Past —
Community Engagement Evaluation and Data Coordination (CEED) Hub to Advance Data and Practice Transformation for Optimizing Oral Health for All (U01, Clinical Trial Not Allowed) RFA-DE-27-001 Closed
Accelerating Product Excellence in Innovation and for Clinical Adoption (APEx) (U24 Clinical Trial Not Allowed) RFA-DE-27-002 Closed
Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) RFA-OD-27-008 Open
HEAL INITIATIVE: INTERACT Data Coordination and Integration Center (U24 Clinical Trial Not Allowed) RFA-AR-27-002 Closed
Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed) PAR-25-415 Open
Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) PAR-25-322 Open
Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Human Required) PAR-25-323 Closed
Community-Based Participatory Research to Advance Data and Practice Transformation (ADAPT) for Optimizing Oral Health for All (UG3/UH3 Clinical Trial Optional) PAR-27-015 Open
HEAL Initiative: Limited Competition for the HEALthy Brain and Child Development (HBCD) Study - Consortium Administrative Core and Data Coordinating Center (U24 Clinical Trial Not Allowed) RFA-DA-27-014 Closed
Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed) PAR-25-414 Open
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) PA-25-425 Open
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31) PA-25-422 Open
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) PA-25-423 Open
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33) PA-25-424 Open
Show 40 more

Latest 50 listed here. See the rest on GovTribe.

Grant awards

Award Recipient Federal obligations Awarded
NG2/CSPG4 in mandibular endochondral fracture healing F30DE033287 University Of Illinois $273,014
Intercepting the evolution of pro-tumoral myeloid cells during the initiation of oral cancer F31DE033922 Regents Of The University Of Michigan $275,574
Uncovering molecular mechanism of hyoid arch deficiencies in ciliopathies. F31DE036078 Childrens Hospital Medical Center $43,855
SLIT3/ROBO1 signaling in jaw bone development F31DE036429 The Curators Of The University Of Missouri $37,163
Defining physiological and behavioral signatures of orofacial pain in mice F31DE036418 Regents Of The University Of Michigan $44,958
Investigating the role of AP-1 during craniofacial ligament regeneration F31DE036094 The Trustees Of Columbia University In The City Of New York $50,914
Systemic bile acid dysregulation drives alveolar bone loss in colitis F30DE036430 The Medical University Of South Carolina $55,914
Regulation of TGF-beta superfamily signaling in the neural crest lineage and craniofacial pathology F31DE036114 The Research Foundation For The State University Of New York $42,578
Predicting oral squamous cell carcinoma transformation through invasion associated biomarkers in oral epithelial… F31DE036085 Regents Of The University Of Michigan $50,914
Mechanical regulation of tumor invasion and immune evasion in head and neck cancer - this F31 predoctoral fellowship… F31DE036475 The Trustees Of The University Of Pennsylvania $26,145

Latest 10 of 10,479 listed here. See the rest on GovTribe.

Top recipients by federal obligations

10 of 628 recipients listed here. See the rest on GovTribe.

Federal obligations by fiscal year

Fiscal year Federal obligations
FY2026 $392,058,274
FY2025 $647,224,598
FY2024 $920,093,638
FY2023 $1,006,148,032
FY2022 $815,458,489
FY2021 $694,099,538
FY2020 $349,123,061
FY2019 $338,552,775
FY2018 $328,858,843
FY2017 $309,053,531
FY2016 $301,972,250
FY2015 $291,386,911
FY2014 $289,037,367
FY2013 $277,446,640
FY2012 $300,506,037
FY2011 $302,774,021
FY2010 $311,392,237
FY2009 $299,395,534
FY2008 $136,231,846
FY2007 $207,854,412
FY2006 $261,823,617
FY2005 $280,731,747
FY2004 $280,125,927
FY2003 $256,989,234
FY2002 $234,642,751
FY2001 $108,512,752
Show all 26

Quick answers

What is Assistance Listing 93.121?

Assistance Listing 93.121 is Oral Diseases and Disorders Research, a federal grant program run by National Institutes of Health (Department of Health and Human Services).

What is the CFDA number for Oral Diseases and Disorders Research?

Its CFDA number is 93.121: Assistance Listing numbers were called CFDA numbers before 2018.

How much funding has Assistance Listing 93.121 awarded?

10,479 grant awards under 93.121 have obligated $11,573,534,602 in federal funds to 628 recipients.

Who receives the most funding from 93.121?

The recipients obligated the most under Oral Diseases and Disorders Research are Fred Hutchinson Cancer Center ($1,346,807,896), Regents Of The University Of Michigan ($411,848,863) and The Regents Of The University Of California. San Francisco ($406,481,065).

How much did 93.121 obligate in fiscal year 2025?

Grants under 93.121 obligated $647,224,598 in federal funds in fiscal year 2025.

Are there open grant opportunities under 93.121?

39 of the latest 50 opportunities under 93.121 are open or forecasted. The latest, Investigator-Focused Award (Parent R35), was posted on July 30, 2026.

On GovTribe

See this program's full record

  • Every grant award and opportunity under it
  • Funding by recipient, agency and assistance type
  • Alerts for new opportunities
  • Ask GovTribe AI about this program